Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Neuroscience

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    February 2024
  1. XU M, Lin R, Wen H, Wang Y, et al
    Electroacupuncture Enhances the Functional Connectivity of Limbic System to Neocortex in the 5xFAD Mouse Model of Alzheimer's Disease.
    Neuroscience. 2024 Feb 27:S0306-4522(24)00090.
    PubMed     Abstract available


  2. ZHANG H, Yang Y, Zhang J, Huang L, et al
    Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia.
    Neuroscience. 2024;538:1-10.
    PubMed     Abstract available


    January 2024
  3. QIAO Y, Liu H, He C, Ma Y, et al
    ApoE Mimic Peptide COG1410 Reduces Abeta Deposition and Improves Cognitive Function by Inducing the Transformation of A1/A2 Reactive Astrocytes and Increasing the BDNF Concentration in Brain of APP/PS1 Double Transgenic Mice.
    Neuroscience. 2024;537:116-125.
    PubMed     Abstract available


  4. ALIASHRAFI M, Nasehi M, Zarrindast MR, Joghataei MT, et al
    Intracerebroventricular Cutibacterium acnes generates manifestations of Alzheimer's disease-like pathology in the rat hippocampus.
    Neuroscience. 2024 Jan 22:S0306-4522(24)00023.
    PubMed     Abstract available


    November 2023
  5. WANG Q, Guo S, Hu D, Dong X, et al
    Enhanced GSDME-mediated pyroptosis in Alzheimer's disease.
    Neuroscience. 2023 Nov 7:S0306-4522(23)00491.
    PubMed     Abstract available


    September 2023
  6. ELDEEN MAKKI B, Rahman S
    Erratum to "Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect" [Neuroscience 530 (2023) 79-94].
    Neuroscience. 2023 Sep 26:S0306-4522(23)00427.
    PubMed    


  7. LIU S, Zheng Y, Li H, Pan M, et al
    Improving Alzheimer Diagnoses with an interpretable Deep Learning Framework: including Neuropsychiatric Symptoms.
    Neuroscience. 2023 Sep 12:S0306-4522(23)00411.
    PubMed     Abstract available


    August 2023
  8. ELDEEN MAKKI B, Rahman S
    Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect.
    Neuroscience. 2023 Aug 29:S0306-4522(23)00402.
    PubMed     Abstract available


  9. WANG L, Wei Y, Sun Z, Jiang LH, et al
    DpdtpA, A Multi-metal Ion Chelator, Attenuates Tau Phosphorylation and Microglial Inflammatory Response via Regulating the PI3K/AKT/GSK-3beta Signal Pathways.
    Neuroscience. 2023;526:196-203.
    PubMed     Abstract available


  10. LIN LL, Song GJ, Zhang H, Yin Y, et al
    GPR34 knockdown relieves cognitive deficits and suppresses neuroinflammation in Alzheimer's disease via the ERK/NF-kappaB signal.
    Neuroscience. 2023 Aug 7:S0306-4522(23)00342.
    PubMed     Abstract available


  11. YANG P, Liao C, Hu Q, Zhang J, et al
    Benzene, 1,2,4-Trimethoxy-5-(2-Methyl-1-Propen-1-yl) Attenuates D-galactose/AlCl(3)-induced Cognitive Impairment by Inhibiting Inflammation, Apoptosis, and improving Expression of Memory-Related Proteins.
    Neuroscience. 2023;524:242-255.
    PubMed     Abstract available


    June 2023
  12. WANG H, Zhang Z, Sittirattanayeungyong S, Hongpaisan J, et al
    ApoE4-related microvascular disease in the Alzheimer's disease hippocampal CA1 stratum radiatum.
    Neuroscience. 2023 Jun 27:S0306-4522(23)00289.
    PubMed     Abstract available


  13. GUNAWARDENA R, Sarrigiannis PG, Blackburn DJ, He F, et al
    Kernel-based Nonlinear Manifold Learning for EEG-based Functional Connectivity Analysis and Channel Selection with Application to Alzheimer's Disease.
    Neuroscience. 2023 Jun 8:S0306-4522(23)00253.
    PubMed     Abstract available


  14. LI Y, Fan H, Ni M, Zhang W, et al
    Targeting lncRNA NEAT1 hampers Alzheimer's disease progression.
    Neuroscience. 2023 Jun 5:S0306-4522(23)00103.
    PubMed     Abstract available


  15. FROST J, Schmitzer B, Topperwien M, Eckermann M, et al
    3d Virtual Histology Reveals Pathological Alterations of Cerebellar Granule Cells in Multiple Sclerosis.
    Neuroscience. 2023;520:18-38.
    PubMed     Abstract available


    May 2023
  16. MOLINERO N, Anton-Fernandez A, Hernandez F, Avila J, et al
    Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration.
    Neuroscience. 2023;518:141-161.
    PubMed     Abstract available


  17. FOUREST-LIEUVIN A, Vinit A, Blot B, Perrot A, et al
    Controlled Tau Cleavage in Cells Reveals Abnormal Localizations of Tau Fragments.
    Neuroscience. 2023;518:162-177.
    PubMed     Abstract available


  18. GALLO D, Ruiz A, Sanchez-Juan P
    Genetic Architecture of Primary Tauopathies.
    Neuroscience. 2023;518:27-37.
    PubMed     Abstract available


  19. JIMENEZ JS
    Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein.
    Neuroscience. 2023;518:70-82.
    PubMed     Abstract available


  20. SCHULZ L, Ramirez P, Lemieux A, Gonzalez E, et al
    Tau-Induced Elevation of the Activity-Regulated Cytoskeleton Associated Protein Arc1 Causally Mediates Neurodegeneration in the Adult Drosophila Brain.
    Neuroscience. 2023;518:101-111.
    PubMed     Abstract available


  21. BERROCAL M, Mata AM
    The Plasma Membrane Ca(2+)-ATPase, a Molecular Target for Tau-induced Cytosolic Calcium Dysregulation.
    Neuroscience. 2023;518:112-118.
    PubMed     Abstract available


  22. CAAMANO-MORENO M, Gargini R
    Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions.
    Neuroscience. 2023;518:38-53.
    PubMed     Abstract available


  23. ANDRES-BENITO P, Carmona M, Pirla MJ, Torrejon-Escribano B, et al
    Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology.
    Neuroscience. 2023;518:119-140.
    PubMed     Abstract available


  24. CONCEPCION FA, Ekstrom NA, Khan MN, Estes OO, et al
    Progressive Dysregulation of Tau Phosphorylation in an Animal Model of Temporal Lobe Epilepsy.
    Neuroscience. 2023 May 2:S0306-4522(23)00193.
    PubMed     Abstract available


    April 2023
  25. KLEPL D, He F, Wu M, Blackburn DJ, et al
    Cross-Frequency Multilayer Network Analysis with Bispectrum-based Functional Connectivity: A Study of Alzheimer's Disease.
    Neuroscience. 2023 Apr 28:S0306-4522(23)00167.
    PubMed     Abstract available


  26. MURRAY HC, Saar G, Bai L, Bouraoud N, et al
    Progressive Spread of Beta-amyloid Pathology in an Olfactory-driven Amyloid Precursor Protein Mouse Model.
    Neuroscience. 2023;516:113-124.
    PubMed     Abstract available


    March 2023
  27. REN S, Li J, Huang L, Huang Q, et al
    Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.
    Neuroscience. 2023;513:137-144.
    PubMed     Abstract available


    February 2023
  28. PLACHEZ C, Tsytsarev V, Zhao S, Erzurumlu RS, et al
    Amyloid Deposition and Dendritic Complexity of Corticocortical Projection Cells in Five Familial Alzheimer's Disease Mouse.
    Neuroscience. 2023;512:85-98.
    PubMed     Abstract available


  29. LOU T, Tao B, Chen M
    Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
    Neuroscience. 2023 Feb 2:S0306-4522(23)00055.
    PubMed     Abstract available


  30. FRANCIOTTI R, Nardini D, Russo M, Onofrj M, et al
    Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment.
    Neuroscience. 2023 Feb 2:S0306-4522(23)00047.
    PubMed     Abstract available


    January 2023
  31. CHEN J, Bai X, Wu Q, Chen L, et al
    Exercise protects against cognitive injury and inflammation in Alzheimer's disease through elevating miR-148a-3p.
    Neuroscience. 2023 Jan 18:S0306-4522(23)00012.
    PubMed     Abstract available


  32. PUIG-PARNAU I, Garcia-Brito S, Vila-Soles L, Riberas A, et al
    Intracranial self-stimulation of the medial forebrain bundle ameliorates memory disturbances and pathological hallmarks in an Alzheimer's disease model by intracerebral administration of amyloid-beta in rats.
    Neuroscience. 2023 Jan 13:S0306-4522(23)00009.
    PubMed     Abstract available


  33. WANG X, Zuo XN
    Parsing an early stage of Alzheimer's disease: Obj-SCD versus SCD.
    Neuroscience. 2023 Jan 12:S0306-4522(23)00010.
    PubMed    


    December 2022
  34. ROSSINI PM, Miraglia F, Vecchio F
    Commentary on Comparison of Machine Learning-based Approaches to Predict the Conversion to Alzheimer's Disease from Mild Cognitive Impairment.
    Neuroscience. 2022 Dec 30:S0306-4522(22)00626.
    PubMed    


  35. BLACKWELL AA, Jodelka FM, I Lake R, Hastings ML, et al
    Spatial disorientation under dark conditions across development in an Alzheimer's disease mouse model.
    Neuroscience. 2022 Dec 29:S0306-4522(22)00620.
    PubMed     Abstract available


  36. LI Y, Fan H, Han X, Sun J, et al
    PR-957 suppresses Th1 and Th17 cell differentiation via inactivating PI3K/AKT pathway in Alzheimer's disease.
    Neuroscience. 2022 Dec 26:S0306-4522(22)00538.
    PubMed     Abstract available


  37. SIMOES JLB, Sobierai LD, Leal IF, Dos Santos MVR, et al
    Action of the purinergic and cholinergic anti-inflammatory pathways on oxidative stress in patients with Alzheimer's disease in the context of the COVID-19 pandemic.
    Neuroscience. 2022 Dec 13:S0306-4522(22)00615.
    PubMed     Abstract available


  38. LI H, Huang Z, Gao Z, Zhu W, et al
    Sex difference in general cognition associated with coupling of whole-brain functional connectivity strength to cerebral blood flow changes during Alzheimer's disease progression.
    Neuroscience. 2022 Dec 7:S0306-4522(22)00602.
    PubMed     Abstract available


    November 2022
  39. CHAI GS, Wu JJ, Gong J, Zhou JL, et al
    Activation of beta2-adrenergic Receptor Ameliorates Amyloid-beta-induced Mitophagy Defects and Tau Pathology in Mice.
    Neuroscience. 2022;505:34-50.
    PubMed     Abstract available


  40. ANAND S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, et al
    Resolvins lipid mediators: Potential therapeutic targets in Alzheimer and Parkinson disease.
    Neuroscience. 2022 Nov 10. pii: S0306-4522(22)00546.
    PubMed     Abstract available


  41. YANG L, Nao J
    Focus on Alzheimer's disease: the role of fibroblast growth factor 21 and autophagy.
    Neuroscience. 2022 Nov 10. pii: S0306-4522(22)00548.
    PubMed     Abstract available


  42. RYCHLIK M, Starowicz G, Starnowska-Sokol J, Mlyniec K, et al
    The Zinc-sensing Receptor (GPR39) Modulates Declarative Memory and Age-related Hippocampal Gene Expression in Male Mice.
    Neuroscience. 2022;503:1-16.
    PubMed     Abstract available


    September 2022
  43. LIN L, Ni L, Wang X, Sheng C, et al
    Longitudinal cognitive change and duration of Alzheimer's disease stages in relation to cognitive reserve.
    Neuroscience. 2022 Sep 28. pii: S0306-4522(22)00487.
    PubMed     Abstract available


  44. ZHAI Z, Xie D, Qin T, Zhong Y, et al
    Effect and Mechanism of Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic review and Meta-analysis.
    Neuroscience. 2022 Sep 15. pii: S0306-4522(22)00466.
    PubMed     Abstract available


    August 2022
  45. TORRES-FLORES M, Pena-Ortega F
    Amyloid Beta Alters Prefrontal-dependent Functions Along with its Excitability and Synaptic Plasticity in Male Rats.
    Neuroscience. 2022;498:260-279.
    PubMed     Abstract available


  46. UNGERLEIDER K, Beck JA, Lissa D, Joruiz S, et al
    Delta133p53alpha Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity.
    Neuroscience. 2022;498:190-202.
    PubMed     Abstract available


  47. BIANCHIN MM, Snow Z
    Primary Microglia Dysfunction or Microgliopathy: A Cause of Dementias and Other Neurological or Psychiatric Disorders.
    Neuroscience. 2022;497:324-339.
    PubMed     Abstract available


  48. PATTA PC, de Oliveira EMN, Goulart ACF, Zaluski AB, et al
    Nanoscale Structural Characterization and Impact on Long-term memory of Amyloid-beta42 Oligomeric forms in Zebrafish.
    Neuroscience. 2022;497:271-281.
    PubMed     Abstract available


  49. ZHU Y, Gao M, Huang H, Gao SH, et al
    p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.
    Neuroscience. 2022;496:27-37.
    PubMed     Abstract available


    June 2022
  50. WU Y, Wu X, Gao L, Yan Y, et al
    Abnormal functional connectivity of thalamic subdivisions in alzheimer's disease: A functional magnetic resonance imaging study.
    Neuroscience. 2022 Jun 8. pii: S0306-4522(22)00291.
    PubMed     Abstract available


    May 2022
  51. GUZMAN-RAMOS K, Osorio-Gomez D, Bermudez-Rattoni F
    Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis.
    Neuroscience. 2022 May 30. pii: S0306-4522(22)00271.
    PubMed     Abstract available


  52. LIANG F, Sun F, He B, Wang J, et al
    Treadmill Exercise Promotes Microglial beta-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
    Neuroscience. 2022;491:122-133.
    PubMed     Abstract available


  53. QU W, Canoll P, Hargus G
    Molecular insights into cell type-specific roles in alzheimer's disease: human induced pluripotent stem cell-based disease modeling.
    Neuroscience. 2022 May 12. pii: S0306-4522(22)00235.
    PubMed     Abstract available


    April 2022
  54. ZHANG F, Pan B, Shao P, Liu P, et al
    A Single Model Deep Learning Approach for Alzheimer's Disease Diagnosis.
    Neuroscience. 2022 Apr 7. pii: S0306-4522(22)00149.
    PubMed     Abstract available


    February 2022
  55. CLARK I
    Basic Scientific Evidence Consistent with Etanercept Efficacy Against Alzheimer's Disease.
    Neuroscience. 2022;484:139.
    PubMed    


  56. MACKENZIE JL, Ivanova N, Nell HJ, Giordano CR, et al
    Microglial inflammation and cognitive dysfunction in comorbid rat models of striatal ischemic stroke and alzheimer's disease: effects of antioxidant catalase-SKL on behavioral and cellular pathology.
    Neuroscience. 2022 Feb 3. pii: S0306-4522(22)00047.
    PubMed     Abstract available


    January 2022
  57. ASIH PR, Stefanoska K, Prikas E, Ittner A, et al
    High level forebrain expression of active tau kinase p38gamma exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice.
    Neuroscience. 2022 Jan 11. pii: S0306-4522(22)00012.
    PubMed     Abstract available


  58. HORTA-LOPEZ PH, Mendoza-Franco G, Rodriguez-Cruz F, Torres-Cruz FM, et al
    Association of alpha-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain.
    Neuroscience. 2022 Jan 8. pii: S0306-4522(22)00002.
    PubMed     Abstract available


    December 2021
  59. HAN H, Li X, Gan JQ, Yu H, et al
    Biomarkers derived from alterations in overlapping community structure of resting-state brain functional networks for detecting Alzheimer's disease.
    Neuroscience. 2021 Dec 29. pii: S0306-4522(21)00662.
    PubMed     Abstract available


  60. LI Y, Fan H, Ni M, Zhang W, et al
    Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-kappaB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation.
    Neuroscience. 2021 Dec 22. pii: S0306-4522(21)00551.
    PubMed     Abstract available


  61. AHMADI A, Gispert JD, Navarro A, Vilor-Tejedor N, et al
    Single-cell Transcriptional Changes in Neurodegenerative Diseases.
    Neuroscience. 2021;479:192-205.
    PubMed     Abstract available


    November 2021
  62. DUNCAN MJ, Guerriero LE, Kohler K, Beechem LE, et al
    Chronic fragmentation of the daily sleep-wake rhythm increases amyloid-beta levels and neuroinflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Neuroscience. 2021 Nov 29. pii: S0306-4522(21)00609.
    PubMed     Abstract available


  63. CHINNATHAMBI S, Gorantla NV
    Implications of Valosin-containing Protein in Promoting Autophagy to Prevent Tau Aggregation.
    Neuroscience. 2021;476:125-134.
    PubMed     Abstract available


    October 2021
  64. CHAGNOT A, Barnes SR, Montagne A
    Magnetic Resonance Imaging of Blood-Brain Barrier permeability in Dementia.
    Neuroscience. 2021;474:14-29.
    PubMed     Abstract available


  65. VIARD A, Eustache F, Segobin S
    History of Magnetic Resonance Imaging: A Trip Down Memory Lane.
    Neuroscience. 2021;474:3-13.
    PubMed     Abstract available


    August 2021
  66. ZHANG W, Xiong BR, Zhang LQ, Huang X, et al
    The Role of the GABAergic System in Diseases of the Central Nervous System.
    Neuroscience. 2021;470:88-99.
    PubMed     Abstract available


    June 2021
  67. MANSOUR HM, Fawzy HM, El-Khatib AS, Khattab MM, et al
    Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.
    Neuroscience. 2021 Jun 15. pii: S0306-4522(21)00305.
    PubMed     Abstract available


    May 2021
  68. ALBUS A, Kronimus Y, Neumann S, Vidovic N, et al
    Effects of a Multimerized Recombinant Autoantibody Against Amyloid-beta.
    Neuroscience. 2021;463:355-369.
    PubMed     Abstract available


  69. GUIX FX
    Enhancing Anti-Abeta Properties of Recombinant Autoantibodies.
    Neuroscience. 2021;463:354.
    PubMed    


    April 2021
  70. JUNG H, Yi D, Soo Byun M, Ho Lee J, et al
    Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease.
    Neuroscience. 2021 Apr 15. pii: S0306-4522(21)00179.
    PubMed     Abstract available


  71. NAZANIN HAJJARI S, Sadigh-Eteghad S, Shanehbandi D, Teimourian S, et al
    MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's disease.
    Neuroscience. 2021 Apr 6. pii: S0306-4522(21)00163.
    PubMed     Abstract available


    March 2021
  72. ZENG L, Zhang D, Liu Q, Zhang J, et al
    Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Abeta42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus.
    Neuroscience. 2021;458:141-152.
    PubMed     Abstract available


  73. LEDEZMA C, Coria-Lucero C, Delsouc MB, Casais M, et al
    Effect of an Intracerebroventricular Injection of Aggregated Beta-amyloid (1-42) on Daily Rhythms of Oxidative Stress Parameters in the Prefrontal Cortex.
    Neuroscience. 2021;458:99-107.
    PubMed     Abstract available


    February 2021
  74. WALKER CK, Greathouse KM, Boros BD, Poovey EH, et al
    Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
    Neuroscience. 2021;455:195-211.
    PubMed     Abstract available


  75. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    Corrigendum to "Inhibitor Kappa B Kinase beta, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer's Disease Model" [Neuroscience 452C (2021) 1-12].
    Neuroscience. 2021 Feb 5. pii: S0306-4522(21)00014.
    PubMed    


  76. MONTEIRO-FERNANDES D, Sousa N, Almeida OFX, Sotiropoulos I, et al
    Sex Hormone Depletion Augments Glucocorticoid Induction of Tau Hyperphosphorylation in Male Rat Brain.
    Neuroscience. 2021;454:140-150.
    PubMed     Abstract available


    January 2021
  77. MEHMOOD A, Yang S, Feng Z, Wang M, et al
    A Transfer Learning Approach for Early Diagnosis of Alzheimer's Disease on MRI Images.
    Neuroscience. 2021 Jan 16. pii: S0306-4522(21)00007.
    PubMed     Abstract available


  78. PEAK SL, Gracia L, Lora G, Jinwal UK, et al
    Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Neuroscience. 2021;453:312-323.
    PubMed     Abstract available


    November 2020
  79. AVILA J, Perry G
    A multilevel view of the development of Alzheimer's Disease.
    Neuroscience. 2020 Nov 24. pii: S0306-4522(20)30731.
    PubMed     Abstract available


  80. DOBRI AM, Dudau M, Enciu AM, Hinescu ME, et al
    CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting.
    Neuroscience. 2020 Nov 17. pii: S0306-4522(20)30719.
    PubMed     Abstract available


  81. LUO Y, Sun T, Ma C, Zhang X, et al
    Alterations of Brain Networks in Alzheimer's Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30684.
    PubMed     Abstract available


  82. ZHOU Y, Ge Y, Liu Q, Li YX, et al
    LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Neuroscience. 2020 Nov 13. pii: S0306-4522(20)30688.
    PubMed     Abstract available


    October 2020
  83. CHEN WP, Zhang G, Cheng ZJ, Gu XH, et al
    IKKbeta, modulated by DJ-1/p-VHL, reduces phosphorylated Tau (p-Tau) accumulation via autophagy in Alzheimer's disease model.
    Neuroscience. 2020 Oct 15. pii: S0306-4522(20)30656.
    PubMed     Abstract available


    January 2020
  84. MA K, Yu J, Shao W, Xu X, et al
    Functional Overlaps Exist in Neurological and Psychiatric Disorders: A Proof from Brain Network Analysis.
    Neuroscience. 2020;425:39-48.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.